https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Clin. Cancer Res. 2003 Apr;9(4):1517-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Clin. Cancer Res. 2003 Apr;9(4):1517-272003-04-01 00:00:002003-04-01 00:00:00TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Zhonghua Gan Zang Bing Za Zhi 2003 Apr;11(4):206-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Zhonghua Gan Zang Bing Za Zhi 2003 Apr;11(4):206-82003-04-01 00:00:002019-02-15 08:37:55[Clinical research on the treatment effect of autologous dendritic cell vaccine on the patients with chronic hepatitis B]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Hematology 2003 Apr;8(2):97-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Hematology 2003 Apr;8(2):97-1042003-04-01 00:00:002019-02-15 08:32:45Dendritic cell-based immunotherapy for the treatment of hematological malignancies
